MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-MH-33-0114768
Gemshi Pharmaceuticals Private Limited - pharma in Ulhasnagar, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.1 Cr
▲ 143% YoY
Net profit · FY 2025
₹7.4 Lakh
Net margin 3.5%
EBITDA · FY 2025
₹12.45 Lakh
EBITDA margin 5.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹2.08 Cr
Secured borrowings
Company age
12 yrs
Est. 2014
Directors on board
3
As per MCA filings
About Gemshi Pharmaceuticals Private Limited
Data last updated:
Gemshi Pharmaceuticals Private Limited is a private limited company based in Ulhasnagar, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 November 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24233MH2014PTC259801. Its GSTIN is 27AAFCG8381E2ZE (Maharashtra). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Urmila Vinay Kumar Tiwari and Vinay Kumar Tiwari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Below MIDC Tank Dhobighat Kamla Nehru Nagar Ulhasnagar, Maharashtra, India – 421001.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.1 Cr, a growth of 143% compared to the previous year. For the same year it recorded a net profit of ₹7.4 Lakh (net margin 3.5%) and EBITDA of ₹12.45 Lakh (EBITDA margin 5.9%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 45% over five years.
As per MCA filings, the company has open charges of ₹2.08 Cr on record.
Gemshi Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0114768). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website gemshipharma.com.
Company Details of Gemshi Pharmaceuticals Private Limited
CIN U24233MH2014PTC259801
Registration Number 259801
Incorporation Date 28 November 2014
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0114768
Recognitions & Rankings of Gemshi Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressBelow MIDC Tank Dhobighat Kamla Nehru Nagar Ulhasnagar, Maharashtra, India – 421001
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Gemshi Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Gemshi Pharmaceuticals Private Limited
The main business activity of Gemshi Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Gemshi Pharmaceuticals Private Limited FY 2025 filings available
Gemshi Pharmaceuticals Private Limited reported revenue of ₹2.1 Cr (up 143% YoY) for FY 2025.
Revenue · FY 2025
₹2.1 Cr ▲ 143%
Net profit · FY 2025
₹7.4 Lakh margin 3.5%
EBITDA · FY 2025
₹12.45 Lakh margin 5.9%
Compounded Annual Growth Rate (CAGR) of Gemshi Pharmaceuticals Private Limited
Revenue CAGR growth
1 year
▲ 143%
3 years · compounded
▼ 1%
5 years · compounded
▲ 45%
EBITDA CAGR growth
1 year
▲ 113%
3 years · compounded
▲ 6%
5 years · compounded
▲ 137%
Revenue has grown at a compounded annual rate (CAGR) of 45% over five years, including 143% growth in the latest year. EBITDA rose 113% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Gemshi Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹12.45 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹7.4 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Gemshi Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Gemshi Pharmaceuticals are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Gemshi Pharmaceuticals Private Limited
Gemshi Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Urmila Vinay Kumar Tiwari | Director | 13 Jul 2021 | 5 Years 3 Months | Current |
| Vinay Kumar Tiwari | Director | 18 Aug 2023 | 3 Years 2 Months | Current |
| Jayprakash Dubey | Director | 27 Jul 2018 | 8 Years 2 Months | Current |
Peer Comparison of Gemshi Pharmaceuticals Private Limited
Gemshi Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| K Square Life Sciences Private Limited | ₹2.1 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Gaziabad, Uttar Pradesh, India |
| Yotta Business Ventures Private Limited | ₹2.1 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Ajmer, Rajasthan, India |
| Mihir Synthetics Private Limited | ₹2.1 Cr (FY 2025) | •••• | •••• | 39.0% | •••• | Mumbai, Maharashtra, India |
| Pharma Corner Private Limited | ₹2.1 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Hathras, Uttar Pradesh, India |
| Mediere Pharmaceuticals Private Limited | ₹2.1 Cr (FY 2024) | •••• | •••• | •••• | Nahan, Himachal Pradesh, India | |
| Gemshi Pharmaceuticals Private Limited this company | ₹2.1 Cr (FY 2025) | •••• | •••• | 143.0% | •••• | Ulhasnagar, Maharashtra, India |
| Megmento Pharmaceuticals Private Limited | ₹2.1 Cr (FY 2024) | •••• | •••• | 97.0% | •••• | Bhubaneswar, Odisha, India |
| Lotus Medicare Services Private Limited | ₹2.1 Cr (FY 2017) | •••• | •••• | 4.0% | •••• | Bangalore, Karnataka, India |
| Maxis Healthcare (I) Private Limited | ₹2.09 Cr (FY 2024) | •••• | •••• | 10.0% | •••• | Gokal Puri, Delhi, India |
| Proneness Pharmaceuticals Private Limited | ₹2.09 Cr (FY 2025) | •••• | •••• | 38.0% | •••• | Lucknow, Uttar Pradesh, India |
| Apoteca Pharma Private Limited | ₹2.09 Cr (FY 2024) | •••• | •••• | -29.0% | •••• | Indore, Madhya Pradesh, India |
Peers are the five companies nearest above and the five nearest below Gemshi Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Gemshi Pharmaceuticals Private Limited
Gemshi Pharmaceuticals Private Limited is audited by ASPG & CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ASPG & CO. | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Gemshi Pharmaceuticals Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Gemshi Pharmaceuticals Private Limited
Open charges
₹2.08 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 May 2025 | Others | ₹1.37 Cr | Open |
| 15 May 2025 | Others | ₹71.5 Lakh | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Gemshi Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Gemshi Pharmaceuticals.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Gemshi Pharmaceuticals Private Limited
Gemshi Pharmaceuticals Private Limited has 5 board changes on record since 2018: 3 appointments and 2 cessations. The latest: Vinay Kumar Tiwari was appointed as Director on 18 Aug 2023.
AGM
Gemshi Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 136.96 Lakh with Charge ID 101107417 was registered on 15 May 2025.
Charges
A charge with Others amounted to Rs. 71.50 Lakh with Charge ID 101107318 was registered on 15 May 2025.
Filing
Gemshi Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Vinay Kumar Tiwari was appointed as Director.
Ceased
Kamleshkumar Gangaprasad Tiwari ceased to be Director.
Appointed
Urmila Vinay Kumar Tiwari was appointed as Director.
Ceased
Vinay Kumar Tiwari ceased to be Director.
Appointed
Jayprakash Dubey was appointed as Director.
Incorporation
28 Nov 2014
Gemshi Pharmaceuticals Private Limited was registered on 28 Nov 2014 with Roc Mumbai & aged 11 years 10 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Gemshi Pharmaceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Gemshi Pharmaceuticals Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Gemshi Pharmaceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Gemshi Pharmaceuticals Private Limited
Gemshi Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCG8381E2ZE | Maharashtra | Active | 03 May 2018 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Gemshi Pharmaceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gemshi Pharmaceuticals Private Limited
Gemshi Pharmaceuticals is an active private limited company based in Ulhasnagar, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 November 2014 (12+ years old) and is registered under CIN U24233MH2014PTC259801.
Gemshi Pharmaceuticals reported revenue of ₹2.1 Cr for FY 2025 (up 143% YoY).
Gemshi Pharmaceuticals has 3 current directors:
- Urmila Vinay Kumar Tiwari - Director
- Vinay Kumar Tiwari - Director
- Jayprakash Dubey - Director
Gemshi Pharmaceuticals reported a net profit of ₹7.4 Lakh (net margin 3.5%) and EBITDA of ₹12.45 Lakh (EBITDA margin 5.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Gemshi Pharmaceuticals is -1% over three years and 45% over five years. In the latest year (FY 2025) revenue rose 143%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Gemshi Pharmaceuticals is 27AAFCG8381E2ZE, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Gemshi Pharmaceuticals is U24233MH2014PTC259801. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gemshi Pharmaceuticals was incorporated on 28 November 2014, making it 12+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Gemshi Pharmaceuticals by revenue are K Square Life Sciences Private Limited, Yotta Business Ventures Private Limited, Mihir Synthetics Private Limited, Pharma Corner Private Limited, Mediere Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Vinay Kumar Tiwari was appointed as Director on 18 Aug 2023. Kamleshkumar Gangaprasad Tiwari ceased to be Director on 20 Jul 2021. Urmila Vinay Kumar Tiwari was appointed as Director on 13 Jul 2021. Gemshi Pharmaceuticals has 5 board changes on record in total.
Yes, Gemshi Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0114768).